India’s animal healthcare sector is witnessing strategic expansion as companies diversify across high-growth segments like poultry and aquaculture.
Provet Pharma Private Limited will receive a strategic investment from Growel Formulations Pvt Ltd, an aqua healthcare and nutrition company established in India, the firm stated on Friday.
Growel Formulations Invests in Provet Pharma
📊 Strategic Investment Highlights
- Investor: Growel Formulations
- Company: Provet Pharma
- Sector: Poultry & Aqua Healthcare
- Goal: Portfolio diversification
- Focus: Animal nutrition & health
- Outcome: Entry into poultry market
According to a formal release from Growel, Provet, a poultry healthcare and nutrition company, has a significant presence in the preventive and therapeutic solutions for the poultry and aqua markets.
According to this corporation, the strategic investment would increase its reach across animal species nutrition and healthcare, marking its entry into the high-growth poultry industry. Growel Formulations’ portfolio is anticipated to be greatly expanded beyond aquaculture as a result of the move.
Expanding into High-Growth Poultry Sector
Deal seeks to create a platform that is diverse and driven by science.
Growel Formulations received buy-side advice from Deloitte India Corporate Finance, and Provet Pharma received advice on the transaction from Veda Corporate Advisors, according to a statement from the firm.
Advisory and Strategic Vision
Growel claims that the deal is in line with the business’s long-term goal of creating a diverse, science-driven platform with an emphasis on animal wellness, health, and nutrition.
According to a statement that Mint got from Growel, “the poultry sector remains one of the fastest-growing protein segments, driven by rising protein needs and awareness, enhanced feed technology, and increasing attention on animal health & productivity.”
📈 Growth Strategy
- Focus: Science-driven solutions
- Sector: Fast-growing poultry industry
- Drivers: Protein demand & tech adoption
- Expansion: Beyond aquaculture
- Target: Farmers & integrators
- Vision: Diversified platform
Company Background and Leadership
Two veterinarians, Drs. V Muthu Selvan and S Senthil, along with two investors, created Provet in 2009. As part of this most recent deal, the investors left the company.
The poultry healthcare and nutrition company has a reliable pan-Indian sales and distribution staff and concentrates on creating novel and distinctive products. According to the company, it has recently entered the export market.
Future Expansion and Market Presence
The combined platform is anticipated to improve its value offer and broaden its extensive portfolio of solutions for farmers and integrators in the poultry and aqua categories as a result of this relationship with Growel.
According to media sources, Growel Group, the parent company of Growel Formulations, introduced two pet treats in 2024 as part of its entry into the rapidly expanding pet food market.
At the time, the corporation stated that it intended to invest between ₹80 and ₹100 crore in the project over the following five years.
Disclaimer: This content is for informational purposes only and does not constitute financial or investment advice. Business developments may evolve over time.
